TPMT Antibodies

Santa Cruz Biotechnology features a diverse variety of TPMT monoclonal antibodies for various research applications. TPMT Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Thiopurine S-methyltransferase (TPMT) is a critical enzyme involved in the metabolism of thiopurine drugs, which are commonly used in the treatment of autoimmune diseases and certain cancers. The activity of TPMT is essential for determining the appropriate dosage of medications, as genetic variations in the TPMT gene can significantly affect drug metabolism and patient response. Understanding TPMT function is crucial for optimizing therapeutic strategies and minimizing adverse effects in patients. TPMT research has significant implications for developing personalized treatment approaches and improving patient outcomes. Investigating TPMT expression patterns helps researchers better understand drug metabolism pathways and individual patient responses to therapy. The role of TPMT in pharmacogenomics continues to be an active area of research, with new insights emerging regularly. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing TPMT studies and contributing to the development of more effective, personalized therapeutic strategies.